ATE266632T1 - Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen - Google Patents

Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen

Info

Publication number
ATE266632T1
ATE266632T1 AT02722661T AT02722661T ATE266632T1 AT E266632 T1 ATE266632 T1 AT E266632T1 AT 02722661 T AT02722661 T AT 02722661T AT 02722661 T AT02722661 T AT 02722661T AT E266632 T1 ATE266632 T1 AT E266632T1
Authority
AT
Austria
Prior art keywords
compositions containing
dietary
containing same
therapeutic use
creatine salt
Prior art date
Application number
AT02722661T
Other languages
English (en)
Inventor
Antonietta Buononato
Original Assignee
Biosalts Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosalts Srl filed Critical Biosalts Srl
Application granted granted Critical
Publication of ATE266632T1 publication Critical patent/ATE266632T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02722661T 2001-03-23 2002-03-19 Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen ATE266632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000155A ITRM20010155A1 (it) 2001-03-23 2001-03-23 Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.
PCT/IT2002/000170 WO2002076931A1 (en) 2001-03-23 2002-03-19 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same

Publications (1)

Publication Number Publication Date
ATE266632T1 true ATE266632T1 (de) 2004-05-15

Family

ID=11455369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02722661T ATE266632T1 (de) 2001-03-23 2002-03-19 Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen

Country Status (13)

Country Link
US (1) US6861554B2 (de)
EP (1) EP1292570B1 (de)
CN (1) CN1460102A (de)
AT (1) ATE266632T1 (de)
CA (1) CA2408528C (de)
DE (1) DE60200476T2 (de)
DK (1) DK1292570T3 (de)
ES (1) ES2219633T3 (de)
IT (1) ITRM20010155A1 (de)
MX (1) MXPA02011465A (de)
PT (1) PT1292570E (de)
TR (1) TR200401701T4 (de)
WO (1) WO2002076931A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
DE10208568A1 (de) * 2002-02-27 2003-09-18 Degussa Bioactives Deutschland Verbindung, enthaltend Kreatin, eine Säure-Komponente und/oder einen Komplex-Bildner
US20040186782A1 (en) * 2003-03-21 2004-09-23 Andrew Schydlowsky Custom food
ITRM20040143A1 (it) * 2004-03-19 2004-06-19 Biosalts Srl Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.
JP5119509B2 (ja) * 2006-05-18 2013-01-16 ビーエイチエヌ株式会社 活動意欲向上剤
US20080153897A1 (en) * 2006-09-11 2008-06-26 New Cell Formulations Ltd. Creatine pyroglutamic acid salts and methods for their production and use in individuals
CA2663141C (en) * 2006-09-11 2010-02-09 New Cell Formulations Ltd. Creatine pyroglutamic acid salts and methods for their production and use in individuals
US7329763B1 (en) * 2006-09-11 2008-02-12 New Cell Formulations Ltd Creatine pyroglutamic acid salts and methods for their production and use in individuals
WO2010074591A1 (ru) 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
US20090312419A1 (en) * 2009-08-12 2009-12-17 Kneller Bruce W CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
WO2011019348A1 (en) * 2009-08-12 2011-02-17 Kneller Bruce W CREATINE β-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
BR9808088A (pt) * 1997-03-27 2000-03-08 Michael J Sole Suplemento nutricional, uso do mesmo e métodos de tratamento de um sistema orgânico crìtico e de insuficiência cardìaca congestiva
IT1306186B1 (it) * 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale

Also Published As

Publication number Publication date
ITRM20010155A1 (it) 2002-09-23
US6861554B2 (en) 2005-03-01
PT1292570E (pt) 2004-09-30
MXPA02011465A (es) 2004-02-26
TR200401701T4 (tr) 2004-08-23
EP1292570A1 (de) 2003-03-19
EP1292570B1 (de) 2004-05-12
DK1292570T3 (da) 2004-09-13
DE60200476T2 (de) 2005-05-25
US20030180276A1 (en) 2003-09-25
ES2219633T3 (es) 2004-12-01
DE60200476D1 (de) 2004-06-17
ITRM20010155A0 (it) 2001-03-23
CA2408528A1 (en) 2002-10-03
CA2408528C (en) 2010-04-20
CN1460102A (zh) 2003-12-03
WO2002076931A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
CY1109503T1 (el) Συνθεσεις βρεφικων τροφων που περιλαμβανουν αυξημενες ποσοτητες αλφα-λακταλβουμινης
ATE231872T1 (de) Thiazolopyrimidinderivate
DE50306232D1 (de) Ampholytisches copolymer und dessen verwendung
AU2003246570A1 (en) Production of cis-pellitorin and use as a flavouring
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ATE266632T1 (de) Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
DE60330542D1 (de) Pharmazeutische Zubereitung enthaltend einen NMDA Rezeptor Agonisten für die Behandlung von Bewegungsstörungen
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
DE60108325D1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
IS2597B (is) Lyf samsett úr R,R-formóteróli og siklesóníði
BR0213299A (pt) Utilização de cistationina
BR0213536A (pt) Formulações de xarope de ribavirina
DK1409449T3 (da) Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse
EP2292666A3 (de) Neoplasma-spezifische Antikörper und deren Verwendungen
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
ATE291468T1 (de) Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
MXPA04005226A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.
WO2005089734A3 (en) Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same
MXPA05006326A (es) Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.
ITRM20010029A0 (it) Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
Hong The Role of Protein Synthesis in Activity-Dependent Inactivation of Ca Channel
ITRM20010493A1 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292570

Country of ref document: EP

REN Ceased due to non-payment of the annual fee